Congenital malabsorptive diarrhea 4
MONDO:0012479Congenital malabsorptive diarrhea due to paucity of enteroendocrine cells is an exceedingly rare genetic gastroenterological disease characterized by severe malabsorptive diarrhea and a lack of intestinal enteroendocrine cells. Within the first weeks of life, patients present with vomiting, dehydration, and severe diarrhea unresponsive to various nutrients and formulas, and require home parenteral nutrition. Diabetes mellitus has also been reported.
Also known as: NEUROG3 congenital diarrhea, NEUROG3 congenital diarrhoea, congenital diarrhea caused by mutation in NEUROG3, congenital diarrhoea caused by mutation in NEUROG3, congenital malabsorptive diarrhea due to paucity of enteroendocrine cells, congenital malabsorptive diarrhea type 4, congenital malabsorptive diarrhoea due to paucity of enteroendocrine cells, congenital malabsorptive diarrhoea type 4
8 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Simple drug may cut infection risk after major gut surgery
Disease control CompletedThis study tested whether tranexamic acid, a drug that helps blood clot, can lower the chance of infection after gastrointestinal surgery. Over 3,300 adults at higher risk for complications took part. The goal was to see if the drug reduces surgical site infections compared to a …
Phase: PHASE4 • Sponsor: Bayside Health • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can an online wellness program ease anxiety in chronic disease?
Symptom relief CompletedThis study tested a 12-week online mind-body program for adults with chronic conditions like heart failure, cancer, and liver disease. The program included mindful movement, meditation, breathwork, and coping skills. Researchers measured changes in anxiety, depression, fatigue, a…
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could postbiotics soothe diarrhea? small trial tests new supplement
Symptom relief CompletedThis completed pilot trial tested two postbiotic supplements (ABB S3 and ABB C22) in 100 hospitalized patients with diarrhea or gut symptoms from tube feeding. The goal was to see if these nutritional supplements could ease symptoms like diarrhea, vomiting, and improve stool cons…
Phase: NA • Sponsor: AB Biotek • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC